About Arbro Pharmaceuticals Private Limited
Data last updated: 06 March 2026
Arbro Pharmaceuticals Private Limited is a private limited company based in Na, Delhi, India. It specialises in drug formulation and development, a part of the broader pharmaceuticals sector. Incorporated on 28 June 1985, the company has been in operation for over 41 years.
Registered with ROC Delhi under CIN U24232DL1985PTC021362.
Capital: an authorised share capital of ₹1.99 Cr and a paid-up capital of ₹1.78 Cr. Formerly known as Arbro Pharmaceuticals Ltd. It is led by directors including Sunil Kumar Jaitly and Saurabh Arora.
Last AGM: 30 September 2025. Financial statements filed for year ended 31 March 2025. Office: 6/14 Kirti Nagar Industrialarea New Delhi, Delhi, India.
As per the financials filed for FY 2025, the company reported a revenue of ₹64.16 Cr, a decline of 9% compared to the previous year.
The company has a workforce of approximately 369 employees as per the latest available data. Its group structure includes 1 subsidiary.
The company is associated with 1 brand - Arbro Pharmaceuticals. As per MCA filings, the company has open charges of ₹18.9 Cr and satisfied charges of ₹13.7 Cr on record.
The current compliance status is marked as compliant by the Registrar of Companies. For more details, the company can be reached via its website arbropharma.com.
-
EmailLocked
-
TelephoneLocked
-
Website
-
Social Media
-
Registered Address6/14 Kirti Nagar Industrialarea New Delhi, Delhi, India
-
IndustryPharma, Drug Formulation & Development, Animal Pharmaceuticals & Healthcare
- Historical Financials and ratios
- Shareholding pattern and group structure
- Charges with holder and property details
- Litigation, compliance and MCA filings
- PDF report delivered after checkout
CIN History of Arbro Pharmaceuticals Private Limited
Arbro Pharmaceuticals Private Limited has one previous CIN (Corporate Identification Number): U24232DL1985PLC021362. The current CIN is U24232DL1985PTC021362, which is the unique identifier assigned by the Registrar of Companies.
| CIN | Status |
|---|---|
| U24232DL1985PTC021362 | Current |
| U24232DL1985PLC021362 | Previous |
Associated Brands with Arbro Pharmaceuticals Private Limited
Arbro Pharmaceuticals Private Limited operates one associated brand: Arbro Pharmaceuticals. These brands represent Arbro Pharmaceuticals Private Limited's diversified market presence and brand portfolio.
| Brand | Description | Website |
|---|---|---|
| Manufacturing and exporting of pharmaceutical formulations , trading of raw materials and Research & Development for pharmaceutical Industry | arbropharma.com |
Competitors & Alternatives of Arbro Pharmaceuticals Private Limited
Brands and companies operating in the same space as Arbro Pharmaceuticals Private Limited include Jubilant Life Sciences, Akums, Nectar Lifesciences and 7 more.
| Competitor | Description | Location | Founded |
|---|---|---|---|
Jubilant Life Sciences
|
Company offering a suite of R&D and manufacturing services for small molecules and generics | Noida, India, India | 1978 |
Akums
|
CDMO focusing on spectrum of dosage forms and therapeutic segments | Delhi, India, India | 2004 |
Nectar Lifesciences
|
Cephalosporin APIs and generic formulations are manufactured. | Chandigarh, India, India | 1995 |
Windlas
|
Biopharma regulatory affairs, quality control, and strategy services are provided. | Gurugram, India, India | 2001 |
Unither
|
Contract development and manufacturing organization for proprietary and generic drugs | Paris, France, France | 1993 |
Recipharm
|
Pharmaceutical development and manufacturing services are offered contractually. | Jordbro, Sweden, Sweden | 1995 |
CoreRx
|
CDMO with a focus on early phase drug product development | Clearwater, United States, United States | 2006 |
Aenova Group
|
CDMO services for pharmaceuticals, medical devices, and nutraceuticals are provided. | Starnberg, Germany, Germany | 2008 |
Zambon Pharma
|
APIs and finished drugs are developed and manufactured in pharmaceuticals. | Bresso, Italy, Italy | 1906 |
Leukocare
|
Proprietary stabilizing solutions for biologics formulations are developed. | Munich, Germany, Germany | 2003 |
Business Activity of Arbro Pharmaceuticals Private Limited
Arbro Pharmaceuticals Private Limited is engaged in principal business activities including manufacturing and professional, scientific and technical, with detailed activities including chemical and chemical products, pharmaceuticals, medicinal chemical and botanical products, architecture, engineering activities, technical testing and analysis activities. The company has 2 registered principal business activity segments, demonstrating its operational diversity and market reach.
| Main Activity Group Code | Description of Main Activity | Business Activity Code | Description of Business Activity | Turnover Percentage |
|---|---|---|---|---|
| C | Manufacturing | C6 | Chemical and chemical products, pharmaceuticals, medicinal chemical and botanical products | Locked |
| M | Professional, Scientific and Technical | M4 | Architecture, engineering activities, technical testing and analysis activities | Locked |
Business activity turnover details for Arbro Pharmaceuticals Private Limited
Turnover contribution percentages and historical activity changes require an active report plan.
- Turnover contribution
- Historical classifications
- Filing-level activity changes
Verified entity values are shown only after access is granted.
Auditor Details of Arbro Pharmaceuticals Private Limited
Arbro Pharmaceuticals Private Limited is audited by Satinder Saini & Company for the financial year 2023. The auditor plays a crucial role in ensuring financial transparency and compliance with accounting standards.
| Name | Status | Appointment Date | Cessation Date |
|---|---|---|---|
| Satinder Saini & Company | Locked | Locked | Locked |
Complete auditor history for Arbro Pharmaceuticals Private Limited
Appointment status, appointment dates, cessation dates, and historical auditor changes require an active report plan.
- Appointment status
- Appointment dates
- Cessation dates
- Auditor changes
Verified entity values are shown only after access is granted.
Board of Directors of Arbro Pharmaceuticals Private Limited
Arbro Pharmaceuticals Private Limited is currently managed by 3 directors, with 4 former directors having served the organization. The current Directors play a crucial role in shaping the company's strategic direction and governance.
| Name | Designation | Appointment Date | Tenure | Status |
|---|---|---|---|---|
| Sunil Kumar Jaitly | Whole-Time Director | 05 Dec 1998 | 27 Years 8 Months | Current |
| Saurabh Arora | Director | 05 Aug 2005 | 21 Years 0 Months | Current |
| Vijay Kumar Arora | Managing Director | 28 Jun 1985 | 41 Years 1 Months | Current |
Financials of Arbro Pharmaceuticals Private Limited FY 2025 filings available
Arbro Pharmaceuticals Private Limited reported revenue of ₹64.16 Cr (down 9.00% YoY) for FY 2025.
Ten-year financial statements for Arbro Pharmaceuticals Private Limited
Historical statement values and trend charts require an active report plan.
- Income statements
- Balance sheets
- Cash-flow statements
- Ratios and benchmarks
Verified entity values are shown only after access is granted.
Ownership and Shareholding of Arbro Pharmaceuticals Private Limited
Shareholding and ownership data for Arbro Pharmaceuticals Private Limited
Promoter, institutional, public, and beneficial ownership values require an active report plan.
- Ownership categories
- Historical changes
- Group structure
- FII and DII holdings
Verified entity values are shown only after access is granted.
Group Structure of Arbro Pharmaceuticals Private Limited
Arbro Pharmaceuticals Private Limited has 1 subsidiary company. This group structure data is as of FY 2023. The corporate group structure reflects Arbro Pharmaceuticals Private Limited's business expansion strategy and organizational complexity.
| Company Name | CIN | Shares Held |
|---|---|---|
| Arbro Formulations Private Limited | U24230DL2022PTC395692 | Locked |
Showing major subsidiaries. Total: 1.
Charges & Borrowings of Arbro Pharmaceuticals Private Limited
| Date | Lender | Amount | Status |
|---|---|---|---|
| 08 Jul 2025 | Hdfc Bank Limited | ₹7.98 Lakh | Open |
| 08 Mar 2021 | Hdfc Bank Limited | ₹17.88 Lakh | Open |
| 28 Aug 2020 | Hdfc Bank Limited | ₹5.21 Lakh | Open |
| 28 Aug 2018 | Hdfc Bank Limited | ₹4.14 Lakh | Open |
| 28 Aug 2018 | Hdfc Bank Limited | ₹4.34 Lakh | Open |
Total charge records: 19 View all charges
Employees and EPFO Compliance at Arbro Pharmaceuticals Private Limited
Arbro Pharmaceuticals Private Limited has a workforce of 369 employees as of Aug 31, 2024.
Employee and EPFO history for Arbro Pharmaceuticals Private Limited
Monthly headcount, contribution history, establishment records, and filing compliance require an active report plan.
- Monthly headcount
- PF contributions
- ECR filing status
- Establishment history
Verified entity values are shown only after access is granted.
GST Compliance of Arbro Pharmaceuticals Private Limited
GST registrations and filing compliance for Arbro Pharmaceuticals Private Limited
State-wise registrations, return filing status, HSN and SAC details, and jurisdiction records require an active report plan.
- GSTIN registrations
- State-wise filing status
- HSN and SAC details
- Tax jurisdiction records
Verified entity values are shown only after access is granted.
Credit Ratings, Litigation & Regulatory Alerts for Arbro Pharmaceuticals Private Limited
Credit ratings, litigation, and regulatory alerts for Arbro Pharmaceuticals Private Limited
Agency ratings, court records, regulatory events, and entity-specific compliance alerts require an active report plan.
- Rating history
- Court and tribunal cases
- Regulatory alerts
- Director-linked violations
Verified entity values are shown only after access is granted.
MSME Payment Delays by Arbro Pharmaceuticals Private Limited
MSME payment history for Arbro Pharmaceuticals Private Limited
Amounts outstanding to micro and small suppliers, delay reasons, and MSME-1 filing history require an active report plan.
- Outstanding amounts
- Delay periods and reasons
- MSME-1 filing history
- Vendor payment signals
Verified entity values are shown only after access is granted.
Subsidiaries & Group Companies of Arbro Pharmaceuticals Private Limited
Corporate group structure for Arbro Pharmaceuticals Private Limited
Parent, subsidiary, associate, joint venture, and ownership records require an active report plan.
- Parent company
- Subsidiaries and ownership
- Associates and joint ventures
- Entity investments
Verified entity values are shown only after access is granted.
MCA Filings & Documents of Arbro Pharmaceuticals Private Limited
MCA filings and documents for Arbro Pharmaceuticals Private Limited
Official forms, annual returns, financial statements, charge filings, and document dates require an active report plan.
- Incorporation documents
- Annual returns and statements
- Charge filings
- Complete filing index
Verified entity values are shown only after access is granted.
Recent Activity on Arbro Pharmaceuticals Private Limited
Recent News on Arbro Pharmaceuticals Private Limited
Frequently Asked Questions about Arbro Pharmaceuticals Private Limited
Arbro Pharmaceuticals Private Limited is an active private limited company in the pharma sector based in Na, Delhi, India. It was incorporated on 28 June 1985 (41+ years old) and is registered under CIN U24232DL1985PTC021362. The company has 369 employees.
Arbro Pharmaceuticals Private Limited reported revenue of ₹64.16 Cr for FY 2025 (down 9.00% YoY).
The current directors of Arbro Pharmaceuticals Private Limited are:
- Sunil Kumar Jaitly - Whole-Time Director
- Saurabh Arora - Director
- Vijay Kumar Arora - Managing Director
The primary industry of Arbro Pharmaceuticals Private Limited is pharma. The company specifically operates in drug formulation and development. The company is currently active in this sector.
Arbro Pharmaceuticals Private Limited can be reached at the registered office: 614 Kirti Nagar Industrialarea New Delhi, Delhi, India, or through the website arbropharma.com.
The authorised capital is ₹1.99 Cr, and the paid-up capital is ₹1.78 Cr.